Ito H - Search Results

1

Efficacy and safety of laparoscopic surgery for pheochromocytoma.

Naya Y, Ichikawa T, Suzuki H, Komiya A, Nagata M, Ueda T, Yamaguchi K, Ito H. Naya Y, et al. Among authors: ito h. Int J Urol. 2005 Feb;12(2):128-33. doi: 10.1111/j.1442-2042.2005.01015.x. Int J Urol. 2005. PMID: 15733105

2

Laparoscopic adrenalectomy in patients with large adrenal tumors.

Naya Y, Suzuki H, Komiya A, Nagata M, Tobe T, Ueda T, Ichikawa T, Igarashi T, Yamaguchi K, Ito H. Naya Y, et al. Among authors: ito h. Int J Urol. 2005 Feb;12(2):134-9. doi: 10.1111/j.1442-2042.2005.01017.x. Int J Urol. 2005. PMID: 15733106

3

Chromogranin a concentration as a serum marker to predict prognosis after endocrine therapy for prostate cancer.

Isshiki S, Akakura K, Komiya A, Suzuki H, Kamiya N, Ito H. Isshiki S, et al. Among authors: ito h. J Urol. 2002 Feb;167(2 Pt 1):512-5. doi: 10.1016/S0022-5347(01)69075-X. J Urol. 2002. PMID: 11792908

4

Clinical characteristics of prostate cancer in elderly Japanese patients 80 years of age or older.

Suzuki H, Akakura K, Ueda T, Mikami K, Tobe T, Komiya A, Ichikawa T, Igarashi T, Ito H. Suzuki H, et al. Among authors: ito h. Eur Urol. 2002 Feb;41(2):172-7. doi: 10.1016/s0302-2838(01)00036-7. Eur Urol. 2002. PMID: 12074405 Clinical Trial.

5

Perivesical abscess caused by migration of a fish bone from the intestinal tract.

Imamoto T, Tobe T, Mizoguchi K, Ueda T, Igarashi T, Ito H. Imamoto T, et al. Among authors: ito h. Int J Urol. 2002 Jul;9(7):405-6. doi: 10.1046/j.1442-2042.2002.00480.x. Int J Urol. 2002. PMID: 12165024 Free article.

6

Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.

Kawana Y, Ichikawa T, Suzuki H, Ueda T, Komiya A, Ichikawa Y, Furuya Y, Akakura K, Igarashi T, Ito H. Kawana Y, et al. Among authors: ito h. Prostate. 2002 Sep 15;53(1):60-4. doi: 10.1002/pros.10131. Prostate. 2002. PMID: 12210480

7

Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy.

Kamiya N, Akakura K, Suzuki H, Isshiki S, Komiya A, Ueda T, Ito H. Kamiya N, et al. Among authors: ito h. Eur Urol. 2003 Sep;44(3):309-14; discussion 314. doi: 10.1016/s0302-2838(03)00303-8. Eur Urol. 2003. PMID: 12932928

8

Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.

Suzuki H, Akakura K, Igarashi T, Ueda T, Ito H, Watanabe M, Nomura F, Ochiai T, Shimada H. Suzuki H, et al. Among authors: ito h. J Urol. 2004 Jan;171(1):182-6. doi: 10.1097/01.ju.0000101501.54931.4a. J Urol. 2004. PMID: 14665872

9

Alternative antiandrogens to treat prostate cancer relapse after initial hormone therapy.

Kojima S, Suzuki H, Akakura K, Shimbo M, Ichikawa T, Ito H. Kojima S, et al. Among authors: ito h. J Urol. 2004 Feb;171(2 Pt 1):679-83. doi: 10.1097/01.ju.0000106190.32540.6c. J Urol. 2004. PMID: 14713785

10

Clinical evaluation of transrectal power doppler imaging in the detection of prostate cancer.

Inahara M, Suzuki H, Nakamachi H, Kamiya N, Shimbo M, Komiya A, Ueda T, Ichikawa T, Akakura K, Ito H. Inahara M, et al. Among authors: ito h. Int Urol Nephrol. 2004;36(2):175-80. doi: 10.1023/b:urol.0000034664.39784.33. Int Urol Nephrol. 2004. PMID: 15368688

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,356 results

Search Page

Filters